We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Cleared in Alabama for Medicaid Drug Price Lawsuit
Drugmakers Cleared in Alabama for Medicaid Drug Price Lawsuit
January 29, 2010
AstraZeneca, GlaxoSmithKline and Novartis do not have to pay fines or damages now that the Alabama Supreme Court has refused to reconsider its decision that the companies did not mislead the state to overpay for drugs reimbursed through Medicaid.